BioSpace News Archive

High demand for cell sorting in stem cell research and increase in prevalence of chronic diseases across the globe are driving growth of the cell sorting market.

Vir Biotechnology, Inc. (Nasdaq: VIR) today announced an expansion of its partnership with the Bill & Melinda Gates Foundation to include the advancement of innovative platform technologies in the development of broadly neutralizing antibodies designed to provide a “vaccinal effect” for the treatment of HIV and prevention of malaria.

Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced preliminary financial results for the quarter and year ending December 31, 2021. Highlights for the fourth quarter and full-year 2021 are presented below.

PreveCeutical commenced its own action against some of the defendants to the Action claiming damages for fraud, conspiracy, breach of contract, and other wrongs with respect to the same transactions which are the subject of the claims asserted in the Action (the “PreveCeutical Action”).

As of 2020, there were 37.7 million people globally living with HIV and 680,000 people died from AIDS-related illnesses last year.

Tempus, a leader in artificial intelligence and precision medicine, today announced the commencement of an open label phase II study, in collaboration with GlaxoSmithKline (GSK) to evaluate the efficacy and safety of ZEJULA (niraparib), a poly (ADP-ribose) polymerase (PARP) inhibitor used for patients with advanced or metastatic solid tumors and a germline or somatic PALB2 mutation.

NeonMind Biosciences Inc. announced today the appointment of Dr. Daniel Bainbridge, MD, FRCPC, past President of the Canadian Anesthesiologists Society.

Avaneer Health today announced several industry-leading organizations have committed a total of $50 million in seed funding to the venture.

Today, leading global health and wellness agency, Evoke , announced three key leadership hires to its executive team.

Bluejay Diagnostics, Inc. today reported that it has completed 90 subjects in the prospective multicenter clinical study addressing rapid IL-6 test for COVID-19 patients with critical care.